diet drug semaglutide GLP-1 Injections for Medical Weight Loss What's New in Obesity Treatment?

Do not use in the eyes, mouth, or vagina

Studies have found ways that people can reduce or prevent weight gain and even continue to lose weight after stopping a GLP-1

However, the in vitro data firmly demonstrated that GLP-1R silencing decreased the malignant ability of PDAC cells

In December 2025, the FDA also greenlit an oral version with the Wegovy pill, offering more flexibility for those who prefer not to use injections

Animal infusion models do show blunting with continuous exposure, which is expected for any GPCR agonist

A weight loss 5% occurred in 54.3, 40.4, and 21.4% of patients, respectively, and a weight loss 10% occurred in 25.2, 15.9, and 6.7% of patients, respectively